Evolus investors frown as FDA declines to approve Botox rival

News

Cosmetics / News 20 Views 0

… product to Allergan Plc’s Botox, citing deficiencies related to the … , a Botox-like treatment. Allergan’s Botox is the market leader for … to develop a biosimilar to Botox. A likely delay for Evolus …

Comments